We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.27B
AUM Growth
+$3.84M
Cap. Flow
-$212M
Cap. Flow %
-4.96%
Top 10 Hldgs %
17.95%
Holding
138
New
2
Increased
8
Reduced
124
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 20.33%
2 Technology 18.87%
3 Healthcare 16.08%
4 Financials 15.34%
5 Consumer Discretionary 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
26
Huron Consulting
HURN
$2.41B
$47.8M 1.12%
958,589
-17,699
-2% -$884K
AIMC
27
DELISTED
Altra Industrial Motion Corp
AIMC
$47.6M 1.12%
922,658
-24,316
-3% -$1.34M
NVRI icon
28
Enviri
NVRI
$623M
$46.9M 1.1%
2,809,017
-86,989
-3% -$1.4M
WSC icon
29
WillScot Mobile Mini Holdings
WSC
$4.39B
$46.4M 1.09%
1,135,789
-30,615
-3% -$1.13M
CUBI icon
30
Customers Bancorp
CUBI
$2.66B
$45.8M 1.07%
699,968
-372,074
-35% -$20.4M
FCN icon
31
FTI Consulting
FCN
$4.4B
$45.7M 1.07%
298,083
-15,288
-5% -$2.23M
PBH icon
32
Prestige Consumer Healthcare
PBH
$2.38B
$45.5M 1.07%
750,597
-17,414
-2% -$1.03M
CCRN
33
DELISTED
Cross Country Healthcare
CCRN
$44.7M 1.05%
1,609,371
-14,175
-0.9% -$344K
KRA
34
DELISTED
Kraton Corporation
KRA
$42.5M 1%
916,630
-46,947
-5% -$2.15M
EEFT icon
35
Euronet Worldwide
EEFT
$2.72B
$42.4M 0.99%
356,140
-9,734
-3% -$1.16M
NUS icon
36
Nu Skin
NUS
$252M
$41.8M 0.98%
823,380
-18,605
-2% -$827K
HLF icon
37
Herbalife
HLF
$1.29B
$41.6M 0.98%
1,016,765
-25,559
-2% -$1.06M
MATW icon
38
Matthews International
MATW
$866M
$41.5M 0.97%
1,132,170
-26,902
-2% -$974K
PPBI
39
DELISTED
Pacific Premier Bancorp
PPBI
$39.8M 0.93%
994,265
-434,957
-30% -$18M
BOX icon
40
Box
BOX
$4.37B
$39.1M 0.92%
1,493,523
-36,059
-2% -$929K
BKU icon
41
Bankunited
BKU
$3.37B
$38.8M 0.91%
917,660
-45,265
-5% -$1.9M
SBNY
42
DELISTED
Signature Bank
SBNY
$37.9M 0.89%
117,301
-48,568
-29% -$15.1M
SUPN icon
43
Supernus Pharmaceuticals
SUPN
$2.59B
$37.5M 0.88%
1,285,872
-32,237
-2% -$978K
BWIN
44
Baldwin Insurance Group
BWIN
$2.69B
$36.8M 0.86%
1,018,488
-24,763
-2% -$915K
QDEL icon
45
QuidelOrtho
QDEL
$1.14B
$36.7M 0.86%
271,725
-6,793
-2% -$945K
HBAN icon
46
Huntington Bancshares
HBAN
$34.4B
$35.9M 0.84%
2,325,960
-120,825
-5% -$1.9M
PACW
47
DELISTED
PacWest Bancorp
PACW
$35.6M 0.83%
787,859
-27,227
-3% -$1.27M
BY icon
48
Byline Bancorp
BY
$1.78B
$34.5M 0.81%
1,260,427
-8,718
-0.7% -$230K
IWM icon
49
iShares Russell 2000 ETF
IWM
$79.8B
$34.4M 0.81%
154,427
+6,238
+4% +$1.41M
FLWS icon
50
1-800-Flowers.com
FLWS
$250M
$34.2M 0.8%
1,462,206
-29,581
-2% -$859K

Similar funds

Aristotle Capital Boston's Q4 2021 Portfolio in Review

As of Q4 2021, Aristotle Capital Boston held 138 positions worth $4.27B, up 0.09% from $4.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aristotle Capital Boston withdrew a net $212M in Q4 2021, closing 4 positions and reducing 124 holdings. Its most notable exit was CAI International, Inc., an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in United Community Banks worth $23.6M.

  • Aristotle Capital Boston's largest Q4 2021 buy was United Community Banks: 655,813 shares worth $23.6M.
  • Aristotle Capital Boston added most to Barnes Group Inc. in Q4 2021, an estimated $16.8M increase.
  • Aristotle Capital Boston's biggest Q4 2021 reduction was Customers Bancorp, cutting an estimated $20.4M.
  • Aristotle Capital Boston fully exited CAI International, Inc. in Q4 2021, selling an estimated $53.6M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $4.27B portfolio in Q4 2021.
  • Aristotle Capital Boston opened 2 new positions and closed 4 in Q4 2021.
  • Aristotle Capital Boston's portfolio value rose 0.09% quarter-over-quarter to $4.27B.

Based on Aristotle Capital Boston's 13F filing for Q4 2021, filed 14 Feb 2022.